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Induction of mucus hypersecretion in the airway epithelium by Th2 cytokines is associated
with the expression of TMEM16A, a Ca2+-activated Cl- channel. We asked whether exposure
of airway epithelial cells to bacterial components, a condition that mimics the highly infected
environment occurring in cystic fibrosis (CF), also results in a similar response. In cultured
human bronchial epithelial cells, treatment with pyocyanin or with a P. aeruginosa culture
supernatant caused a significant increase in TMEM16A function. The Ca2+-dependent Cl-
secretion, triggered by stimulation with UTP, was particularly enhanced by pyocyanin in cells
from CF patients. Increased expression of TMEM16A protein and of MUC5ACmucin by bac-
terial components was demonstrated by immunofluorescence in CF and non-CF cells. We
also investigated TMEM16A expression in human bronchi by immunocytochemistry. We
found increased TMEM16A staining in the airways of CF patients. The strongest signal was
observed in CF submucosal glands. Our results suggest that TMEM16A expression/function
is upregulated in CF lung disease, possibly as a response towards the presence of bacteria
in the airways.
Introduction
The airway epithelium displays a series of defense mechanisms against bacteria and viruses
that reach the airway surface with the inhaled air. In particular, the airways are covered by a
liquid and a mucus layer [1]. The liquid layer, known as the periciliary liquid (PCL), is main-
tained at a fixed thickness of nearly 7 microns through the balance between fluid/electrolyte
secretion and absorption [1,2]. PCL is important to maintain the mucus layer at the optimal
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distance from the airway surface in order to be moved by the beating of cilia [2]. Major players
in the homeostasis of PCL volume and composition are the Na+ and Cl- channels localized on
the apical membrane of airway epithelial cells [1,3]. The epithelial sodium channel ENaC is
responsible for Na+ absorption [4]. A significant fraction of chloride secretion is instead medi-
ated by the cystic fibrosis transmembrane conductance regulator (CFTR), a channel whose
activity is elicited by cAMP-dependent phosphorylation [5]. CFTR loss of function is the basic
defect in cystic fibrosis (CF). Lack of secretion through CFTR causes depletion of the PCL and
impairment of mucociliary transport [2]. As a consequence, the airways are clogged by a highly
viscous mucus that becomes the niche for bacterial colonization. Since CFTR pore is permeable
to bicarbonate, high viscosity of mucus in CF may also depend on defective bicarbonate secre-
tion. Indeed, bicarbonate is required to facilitate mucus release and expansion [6–8].
In addition to CFTR, the airway epithelium also expresses TMEM16A, a Ca2+-activated
Cl- channel [9–12]. The precise role of Ca2+-dependent Cl- secretion in the airways is not
clear. However, TMEM16A expression is strongly upregulated by the Th2 cytokines IL-4 and
IL-13 [9,12,13]. Such cytokines also induce mucous metaplasia, i.e. increased abundance of
mucus-secreting goblet cells [14–17]. This suggests a possible link between TMEM16A and
mucus, a relationship that may be explained with the ability of this channel to transport bicar-
bonate [18].
The expression and role of TMEM16A in CF are not clear. We previously found no differ-
ence in TMEM16A expression and function between CF and non-CF cultured bronchial epi-
thelial cells [12]. Also, both types of cells responded equally to IL-4 with upregulation of
TMEM16A expression and Ca2+-dependent Cl- secretion. However, CF airway epithelial cells
are exposed to bacteria in vivo. Bacterial components may trigger active responses in epithelial
cells, with altered expression of cell proteins. In particular, pyocyanin, a major virulence factor
of P. aeruginosa, and bacterial supernatants were found to induce mucus metaplasia and
MUC5AC expression [19,20]. Since there seems to be a relationship between TMEM16A
expression and mucus hypersecretion [12,13], we asked whether TMEM16A is also affected by
bacterial components. We found that pyocyanin, as well as whole bacterial supernatants from




The isolation, culture, and differentiation methods of primary bronchial epithelial cells were
previously described in detail [12]. Briefly, epithelial cells were obtained from mainstem
human bronchi, derived from CF and non-CF individuals undergoing lung transplant. For this
study, cells were obtained from two CF patients (homozygous for F508del mutation) and two
non-CF patients. Cells were detached by overnight incubation of bronchi at 4°C in a solution
containing protease XIV. Epithelial cells were then cultured in a serum-free medium (LHC9
mixed with RPMI 1640, 1:1) supplemented with various hormones and supplements. This
medium favors cell number amplification. When cells were derived from CF patients, the cul-
ture medium contained in the first days a complex mixture of antibiotics (usually colistin,
piperacillin, and tazobactam) to eradicate bacteria. The collection of bronchial epithelial cells
and their study to investigate the mechanisms of transepithelial ion transport were specifically
approved by the Ethics Committee of the Istituto Giannina Gaslini following the guidelines of
the Italian Ministry of Health. Each patient provided informed consent to the study using a
form that was also approved by the Ethics Committee.
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To obtain differentiated epithelia, cells were seeded at high density on porous membranes
(12 mm Snapwell inserts, Corning, code 3801). After 24 hours, the serum-free medium was
replaced with DMEM/Ham’s F12 containing 2% fetal bovine serum plus hormones and supple-
ments. Differentiation of cells into a tight epithelium was checked by measuring transepithelial
electrical resistance and potential difference with an epithelial voltohmmeter (EVOM1, World
Precision Instruments). The medium was replaced daily on both sides of permeable supports up
to 8–10 days (liquid-liquid culture, LLC). Subsequently the apical medium was totally removed
and the cells received nutrients only from the basolateral side (air-liquid culture, ALC). This
condition favored a further differentiation of the epithelium. Cells were maintained under ALC
for 2–3 weeks before experiments.
To test bacterial components, we added 100 μl of PBS to the apical side of the epithelium
with and without bacterial components. Pyocyanin concentration was 60 μMwhereas the bacte-
rial supernatant was diluted 1:8 into PBS. Higher concentrations of pyocyanin and supernatant
were not studied because they caused a marked decrease in epithelial resistance. To prepare the
bacterial supernatant, the CF clinical P. aeruginosa strain used in this study was grown in M9
medium at 37°C to late log phase and a cell-free culture supernatant was obtained, as described
previously [21]. Briefly, the broth culture was centrifuged at 10,000 rpm for 50 min. The super-
natant containing bacterial exoproducts was sterilized by passage through a 0.22-micron poly-
mer filter (Corning) and kept at -80°C until used.
Short-circuit current recordings
Snapwell inserts carrying differentiated bronchial epithelia were mounted in a vertical diffusion
chamber resembling a Ussing chamber with internal fluid circulation. Both apical and basolat-
eral hemichambers were filled with 5 ml of a solution containing (in mM): 126 NaCl, 0.38
KH2PO4, 2.13 K2HPO4, 1 MgSO4, 1 CaCl2, 24 NaHCO3, and 10 glucose. Both sides were con-
tinuously bubbled with a gas mixture containing 5% CO2 - 95% air and the temperature of the
solution was kept at 37°C. The transepithelial voltage was short-circuited with a voltage-clamp
(DVC-1000, World Precision Instruments) connected to the apical and basolateral chambers
via Ag/AgCl electrodes and agar bridges (1 M KCl in 1% agar). The offset between voltage elec-
trodes and the fluid resistance were canceled before experiments. The short-circuit current was
recorded with a PowerLab 4/25 (ADInstruments) analogical to digital converter connected to a
Macintosh computer.
Intracellular Ca2+ determination
Bronchial epithelial cells on Snapwell inserts were washed in PBS and then loaded for 1 h with
5 μM Fluo-4/AM (Life Technologies) in PBS. Loading solution, applied to both sides of the epi-
thelium, also contained 10 mM glucose, 0.5 mM sulfinpyrazone, and 1% fetal bovine serum.
After loading, cells were rapidly washed and equilibrated in PBS containing 10 mM glucose
and 0.5 mM sulfinpyrazone (250 μl apical, 2 ml basolateral). A six-well plate carrying the Snap-
well inserts with fluorescent cells was then introduced in a BMG FLUOstar Galaxy microplate
reader. The assay consisted of continuous reading of cell fluorescence (excitation: 485 nm;
emission: 520 nm) for 40 s (sampling time: 0.2 s). At 4 s, the reader injected on the apical side
250 μl of PBS containing 10 mM glucose, 0.5 mM sulfinpyrazone, and 200 μMUTP. Each trace
was corrected for the background (Snapwell inserts without cells).
Western blot assays
Cells were lysed in RIPA buffer 1X (50 mM Tris-HCl pH 7.4, 150 mMNaCl, 1% Triton X-
100, 0.5% sodium deoxycholate, 0.1% SDS) containing Complete Protease Inhibitor Cocktail
TMEM16A Upregulation by Pyocyanin
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(Roche, NJ, USA). The protein concentration in lysates was quantified using the Quantum Pro-
tein Assay kit (Euroclone). Total lysates were electrophoresed (30 μg per lane) with NuPAGE
Novex Bis-Tris 4–12% gel (Life Technologies) and transferred to a nitrocellulose membrane
(Bio-Rad, Hercules, CA, USA) for Western blotting. The TMEM16A protein was immunode-
tected with the r [SP31] rabbit monoclonal antibody (ab64085, Abcam; 1:1000). The secondary
antibody was anti-rabbit HRP (Millipore; 1:5000). Membranes were also stripped with the
Restore Western Blot Stripping Buffer (Thermo Fisher Scientific Inc.) and incubated with the
mouse monoclonal C464.8 (Merck Millipore) antibody against Na+/K+-ATPase β1 (1:6000)
followed by anti-mouse HRP-conjugated secondary antibody (Ab 97023, Abcam; 1:10000). All
antibodies were dissolved in 5% skimmed-milk in Tris-buffered saline—Tween 20. Protein
bands were visualized using the ECL Advanced Western Blotting Detection Kit (GE Healthcare
Europe, Little Chalfont, UK). Direct recording of the chemiluminescence was performed using
the Molecular Imager ChemiDoc XRS System (Bio-Rad).
Immunofluorescence
Primary human bronchial epithelial cells on Snapwell permeable supports were rinsed twice
with PBS and fixed by adding 200 μl of 10% neutral buffered formalin (05-01005Q, Bio-Optica)
for 10 minutes. After three washings with PBS, cells were subjected to antigen retrieval with 10
mM citrate buffer pH = 6 heated to 95°C in a microwave for 5 minutes. Samples were then
cooled to room temperature in PBS and permeabilized with PBS-Triton X-100 0.3% for 5 min-
utes. After washing, cells were blocked with 1% bovine serum albumin (BSA) in PBS for 2 hours
and then incubated overnight at 4°C with 200 μl of primary antibodies diluted in PBS containing
BSA 1% and Triton X-100 0.3%. The following antibodies and dilutions were used: rabbit
monoclonal anti-TMEM16A [SP31] (ab64085, Abcam) at 1:200, mouse IgG2B anti-acetylated
tubulin (7451, Sigma Aldrich) at 1:300, NCL-HGM-45M1 mouse IgG1 anti-MUC5AC (Novo-
castra) at 1:50.
Following incubation with primary antibodies, cells were rinsed three times in PBS and
incubated with 200 μl of a solution of secondary goat anti-rabbit Alexa Fluor 488, goat anti-
mouse IgG1 Alexa Fluor 546 and goat anti-mouse IgG2B Alexa Fluor 633 antibodies (Life
Technologies) diluted at 1:200 in PBS-BSA 1% for 1 hour in the dark. After further 3 washes in
PBS, the porous membrane carrying the cells was cut from the plastic support of the Snapwell,
placed on microscope slides and mounted with Fluoroshield with 4',6-diamidino-2-phenylin-
dole (DAPI) (Sigma-Aldrich) to stain cell nuclei.
Confocal microscopy was performed using a laser scanning spectral confocal microscope
TCS SP2-AOBS (Leica Microsystems, Heidelberg, Germany). Image analysis was performed
using Leica and ImageJ software. TMEM16A positive-cells, goblet cells, and total number of
cells (nuclei) were manually counted in xy fields having the size of 375 x 375 μm (at least 4
fields per condition). Each field contained 904 ± 23 cells (at least 4,000–5,000 cells were
counted per condition).
Histology and immunohistochemistry
Tissue samples were obtained from four CF patients (with the following mutations: F508del/
F508del, F508del/R1066H, F508del/G542X, F508del/1717-1G>A) and from two non-CF
patients. Samples were fixed in 4% formalin and embedded in paraffin. For histology, paraffin-
embedded samples were sectioned at 3 μm and stained with hematoxylin and eosin (H&E). For
immunohistochemistry on the formalin-fixed, paraffin-embedded samples, sections were
deparaffinized, subjected to antigen retrieval, treated with H2O2/3% for 5 minutes, to inhibit
endogenous peroxidase, and incubated for 30 minutes with TMEM16A (rabbit anti-human
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TMEM16A, clone SP31 Abcam, Cambridge, UK) antibody. Immune complexes were detected
using the Bond Polymer Refine Detection Kit according to the manufacturer’s protocol (Leica
Biosystems, Wetzlar, Germany).
Statistics
Data are presented as representative traces or as mean values ± SEM. Statistical analysis was
done with one-way ANOVA using the InStat (GraphPad) software.
Results
Human bronchial epithelial cells were allowed to differentiate as a polarized epithelium on
porous supports and then incubated with pyocyanin 60 μM for 24 and 72 hours or with bacte-
rial supernatant for 24 hours. After treatment, cells were studied in short-circuit current
recordings. The experimental protocol included block of ENaC with amiloride (10 μM), stimu-
lation of CFTR activity with CPT-cAMP (100 μM), block of CFTR with CFTRinh-172 (10 μM),
and stimulation of Ca2+-dependent Cl- secretion with UTP (100 μM). All compounds were
added in the apical chamber. CPT-cAMP was also added in the basolateral chamber.
Fig 1 shows data (representative traces and bar graphs) from experiments on non-CF epi-
thelia. Incubation with pyocyanin and supernatant elicited an increase in Ca2+-dependent Cl-
secretion. The largest effect, a more than 2-fold increase in the current peak elicited by UTP,
was observed with pyocyanin at 24 hours. We also observed an increase in ENaC activity
(amiloride-sensitive current) with pyocyanin and bacterial supernatant but these effects did
not reach statistical significance (Fig 1). CFTR function was instead unaffected by treatments.
Pyocyanin was also effective in CF bronchial epithelial cells, particularly at 72 hours (Fig 2).
Under this condition, the UTP peak was increased three-fold. Interestingly, the UTP-depen-
dent current measured in CF cells at 72 hours was significantly larger than that measured in
non-CF cells (21.5 ± 2.37 vs. 10.25 ± 0.48 μA/cm2, p< 0.01). In contrast, the bacterial superna-
tant was ineffective. Pyocyanin at 72 hours also significantly increased the activity of ENaC in
CF cells (Fig 2B). Regarding CFTR, the currents were obviously very small in CF cells under
resting conditions (0.86 ± 0.13 μA/cm2, not shown) and no change was detected in cells treated
with bacterial components. In the same experiments, we also tested IL-4 for comparison. This
resulted, as previously reported [12] in a more than eight-fold increase in UTP-dependent cur-
rent (not shown).
The increase in Ca2+-dependent Cl- secretion induced by bacterial components could be the
result of altered intracellular Ca2+ mobilization and/or upregulation of TMEM16A expression.
To evaluate the first type of mechanism, we measured intracellular Ca2+ with the fluorescent
Fluo-4 probe. Stimulation with apical UTP (100 μM) triggered a fast increase in cytosolic Ca2+
concentration (Fig 3A and 3B). In non-CF cells, we found that pyocyanin treatment did not
alter the amplitude of the UTP-dependent Ca2+ increase (Fig 3A). In CF cells treated with pyo-
cyanin, the response to UTP appeared larger with respect to untreated cells but the difference
was not statistically significant (Fig 3B). To assess a possible effect of pyocyanin on TMEM16A
protein expression, we carried out western blot experiments. In untreated cells, TMEM16A
protein expression was weakly detectable. Pyocyanin treatment markedly increased the
TMEM16A signal (Fig 3C, left panel). We also compared TMEM16A expression induced by
pyocyanin and by IL-4 (Fig 3C, right panel). IL-4 was more effective, in agreement with func-
tional data.
To confirm the upregulation of TMEM16A protein by pyocyanin we used immunofluores-
cence experiments. Cells were stained with antibodies against TMEM16A, MUC5AC, and acet-
ylated tubulin (for ciliated cells). In agreement with functional data, we found that incubation
TMEM16A Upregulation by Pyocyanin
PLOS ONE | DOI:10.1371/journal.pone.0131775 June 29, 2015 5 / 13
with pyocyanin increased the percentage of CF and non-CF cells expressing TMEM16A pro-
tein (Fig 4). Pyocyanin also increased the percentage of cells expressing MUC5AC mucin.
However, only a fraction of MUC5AC-positive cells (nearly 20% in CF epithelia) coexpressed
TMEM16A. No co-expression was found for TMEM16A and tubulin. We also found no differ-
ence when comparing CF and non-CF cells: both types of cells responded similarly to pyocya-
nin (Fig 4).
The in vitro induction of TMEM16A expression by bacterial components led us to ask
whether a similar response occurs also in vivo. Therefore, we performed immunohistochemical
analysis of bronchi from CF and non-CF subjects. We found that, in bronchi from non-CF
subjects, the expression of TMEM16A in the surface epithelium was undetectable (not shown),
whereas in CF bronchi, a slight and unsteady TMEM16A expression was found in the apical
membrane of columnar cells of epithelium (Fig 5Ac, arrows). In CF patients, as in non-CF
Fig 1. Effect of bacterial components on ion transport in cultured bronchial epithelial cells. (A) Representative short-circuit recordings on cultured
non-CF human bronchial epithelial cells. Cells were treated for 24 hours with and without pyocyanin (60 μM) or bacterial culture supernatant. Arrows indicate
the time of addition of amiloride (10 μM), CPT-cAMP (100 μM), CFTRinh-172 (10 μM), and UTP (100 μM). (B) Bar graphs report the amplitude of currents
measured under the indicated conditions. ENaC graph: amiloride-sensitive current; CFTR graph: amplitude of current drop produced by addition of CFTRinh-
172; CaCC graph: maximal current elicited by addition of UTP, which triggers the activation of Ca2+-activated Cl- channels. Each bar is the mean plus SEM of
7–8 experiments. *, p < 0.05; **, p < 0.01 vs. control.
doi:10.1371/journal.pone.0131775.g001
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subjects, we also found staining of microvessels located in the peri-bronchial connective tissue
(Fig 5Ab, arrows).
TMEM16A expression was barely detectable in the bronchial submucosal glands of non-CF
samples (Fig 5Bb). In contrast, in patients with CF, submucosal glands showed a distinct (Fig
5Ad) to strong (Fig 5Af) staining for TMEM16A.
Discussion
TMEM16A protein contributes to Cl- and bicarbonate secretion in various organs and tissues.
In the airways, TMEM16A represents an alternative route for anion transport with respect to
CFTR [9,22]. This is particularly relevant for CF, in which lack of CFTR function causes a
severe impairment of innate defense mechanisms including mucociliary clearance and bacteri-
cidal mechanisms [1,2,23]. Therefore, the extent of TMEM16A expression in CF airways could
potentially modify the lung phenotype and be important in determining the efficacy of thera-
peutic strategies trying to circumvent the CFTR defect.
In previous studies, we and others found that Ca2+-dependent Cl- secretion in cultured
bronchial epithelia is strongly regulated by IL-4 and IL-13 [24,25], two cytokines that mediate
Th2 immune response and induce mucus metaplasia in the airways [14–17]. An increased
anion secretion by allergic airway inflammation was also observed in mice [26]. We subse-
quently found that upregulation of anion secretion by Th2 cytokines is due to increased expres-
sion of the TMEM16A chloride channel protein [9]. This phenomenon also occurred when IL-
4 was applied to CF bronchial epithelia in vitro [12]. However, it is not clear if this also occurs
Fig 2. Upregulation of Ca2+-dependent Cl- secretion by pyocyanin in CF cells. (A) Representative short-circuit recordings on cultured CF bronchial
epithelial cells. Cells were treated with pyocyanin (60 μM, 24 and 72 hours) or with bacterial supernatant (24 hours). The experiments were done as shown in
Fig 1 (sequential addition of amiloride, CPT-cAMP, CFTRinh-172, and UTP). However, for simplicity, only the response to UTP is shown. (B) Bar graphs show
the values measured for ENaC and CaCC. CFTR currents were very small and not affected by treatments. Each bar is the mean plus SEM of 8–9
experiments. *, p < 0.05; **, p < 0.01 vs. control.
doi:10.1371/journal.pone.0131775.g002
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in vivo although there is evidence that the immune response to chronic bacterial infection in
CF is of the Th2 type [27,28].
To reproduce, at least in part, the conditions of the CF airway epithelium in vivo, we treated
cultured bronchial epithelial cells with pyocyanin and bacterial supernatant. Interestingly, both
Fig 3. Analysis of pyocyaninmechanism of action. (A,B)Cytosolic Ca2+ revealed with the fluorescent
Fluo-4 probe in non-CF and CF bronchial epithelial cells, with and without treatment with pyocyanin (60 μM,
24 hours). Top graphs show the time-course of Fluo-4 fluorescence before and after acute stimulation with
apical UTP (100 μM). Each dot is the mean of three experiments. Bottom graphs show the values of
fluorescence measured at the indicated time points. Although the response to UTP in pyocyanin-treated CF
cells was larger than in untreated cells, the difference was not statistically significant. (C)Western blot
analysis of TMEM16A protein expression. Non-CF cells were treated with pyocyanin (60 μM) or IL-4 (10 ng/
ml) for 24 hours. Pyocyanin and, to a larger extent, IL-4 increased TMEM16A expression. Each panel is
representative of three similar experiments.
doi:10.1371/journal.pone.0131775.g003
TMEM16A Upregulation by Pyocyanin
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Fig 4. Expression of TMEM16A protein in cultured bronchial epithelial cells. (A) Representative images
showing detection of TMEM16A (green), MUC5AC (red), and acetylated tubulin (magenta) by
immunofluorescence. Images, taken with a confocal microscope, are xy (top) and xz (bottom) scans of
bronchial epithelial cells treated with and without pyocyanin. The xz images also report staining of nuclei with
DAPI (blue). The blue layer under the cells is the porous membrane of the Snapwell insert. (B) Bar graphs
report the percentage of cells positive for TMEM16A, for MUC5AC, and for both proteins together. *, p < 0.05;
**, p < 0.01 vs. control.
doi:10.1371/journal.pone.0131775.g004
TMEM16A Upregulation by Pyocyanin
PLOS ONE | DOI:10.1371/journal.pone.0131775 June 29, 2015 9 / 13
treatments resulted in upregulation of Ca2+-dependent Cl- secretion, although pyocyanin
appeared more effective than the supernatant. The effect on Cl- secretion was not due to altered
intracellular Ca2+ mobilization but to increased TMEM16A protein expression, a mechanism
of action that is similar, although less potent, than that triggered by IL-4 in bronchial epithelial
cells (9).
Fig 5. Immunohistochemical detection of TMEM16A in human airways. (A) Expression of TMEM16A in the surface epithelium. TMEM16A staining was
mostly absent (b), and sometimes scanty (c) in the respiratory epithelium lining bronchi or bronchioles from CF patients (c, arrows). A weak expression was
also detectable in microvessels of peri-bronchial connective tissue (b, arrows). Magnification: X400. (B) TMEM16A expression was modest in non-CF
submucosal glands of non-CF samples (b) but markedly increased in tissues from CF patients (d), with a particularly strong signal (f) in histologically altered
glands (e). Magnification: X630 in a, X400 in b-f. Images 4Aa and 4Ba,c,e show hematoxylin and eosin staining.
doi:10.1371/journal.pone.0131775.g005
TMEM16A Upregulation by Pyocyanin
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The effect of short-term treatment of pyocyanin on ion transport in a bronchial cell line was
previously investigated [29]. This study found that pyocyanin stimulates CFTR function. In
our study, we found that chronic exposure of primary bronchial epithelial cells does not affect
CFTR function.
In our experiments, pyocyanin also increased the percentage of cells expressing MUC5AC
as found previously by others [19]. The underlying mechanism of action of pyocyanin seems to
be shared with that of Th2 cytokines [19]. However, in our experiments with pyocyanin the
percentage of cells co-expressing MUC5AC and TMEM16A was relatively low compared with
the value previously reported for cells treated with IL-4 [12]. This could indicate that Th2 cyto-
kines and pyocyanin signaling cascades are not identical and that significant differences may
be responsible for the different effect on the extent and site of expression of TMEM16A and
MUC5AC.
Interestingly, we found that pyocyanin treatment affected ENaC function, with a significant
increase in amiloride-sensitive current in CF cells at 72 hours. This effect could result in higher
Na+ ad fluid absorption. Since pyocyanin also increases Cl- secretion through TMEM16A, it
remains to determined which process prevails in vivo.
We also investigated TMEM16A expression by immunohistochemical analysis of bronchi
from CF and non-CF subjects. Intriguingly, TMEM16A expression was undetectable in the
airway surface epithelium of non-CF samples. This contrasts with the presence of a Ca2+
-dependent Cl- secretion that has been reported also in vivo for human airways. The absence of
a TMEM16A signal could be explained with the inability of our antibody to detect a relatively
low, but functionally relevant, expression of this protein. In contrast, TMEM16A staining was
observed in the surface epithelium of CF bronchi, as a possible result of increased expression
triggered by bacterial colonization and inflammation. Actually, the non-homogeneous expres-
sion of TMEM16A in the surface epithelium of CF airways could be explained with different
degrees of infection/inflammation. An unexpected finding of our study was the strong
TMEM16A signal in the submucosal glands of CF patients. In addition to surface epithelium,
glands are another important site for anion secretion. In particular, CFTR-dependent Cl- and
bicarbonate transport is important to support the secretion of mucins and other macromolecules
[8,30,31]. In this respect, it has been recently found in CF pigs that lack of CFTR blocks the
release of mucus from submucosal glands [8]. This results in the accumulation of mucus strands
on the airway surface [8].
Submucosal glands also show a Ca2+-dependent anion secretion, probably mediated by
TMEM16A [32,33]. The relative role of the two channels, CFTR and TMEM16A, in gland
function is unclear, but the former could be involved in basal secretion, whereas the latter
could be instead recruited by neurohumoral stimulation [32]. The upregulation of TMEM16A
in CF glands is particularly intriguing. This phenomenon may result from the presence of an
infected/inflamed environment. If so, this could mean that such conditions are more effective
on glands than on the surface epithelium. Alternatively, it could be hypothesized that increased
TMEM16A expression is an intrinsic response of glands to try to compensate for the absence
of functional CFTR.
Summarizing, we found that bacterial components, specifically pyocyanin, stimulate
TMEM16A expression and function in cultured bronchial epithelial cells. The resulting
increase in Ca2+-activated anion secretion may be important to facilitate the release and trans-
port of MUC5AC mucin, which is also induced by pyocyanin. TMEM16A expression is also
upregulated in CF airways in vivo, particularly in submucosal glands. If this response has some
beneficial effect on mucociliary clearance and other innate defense mechanisms requires fur-
ther investigation. This is required to assess the importance of TMEM16A as a therapeutic
target in CF and, possibly, in other lung diseases characterized by mucus hypersecretion.
TMEM16A Upregulation by Pyocyanin
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